Study of the Combination of a Cyanoacrylate and Surgical Solutions in Reducing Skin Flora Contamination

Inclusion Criteria: * Scheduled for an elective Coronary Artery Bypass Graft (CABG) surgical procedure with median sternotomy utilizing either the saphenous vein and/or radial artery as one of the graft sites within 28 days of the screening date, as documented by a Cardiothoracic Surgeon who is the Principal Investigator or sub-investigator. This includes subjects who are also receiving internal mammary artery grafts in addition to saphenous vein and/or radial artery grafts. * The skin near or around the proposed incision sites should be intact. Exclusion Criteria: * Known sensitivity or allergy to cyanoacrylate, isopropyl alcohol, iodine or iodine-containing products or tape allergies. * Female subjects that are nursing or actively lactating. * Abnormal skin condition adjacent to or at the surgical incision sites. * Hair removal at the surgical sites prior to entrance to the operating suite. * Use of antimicrobial impregnated incise drapes (i.e. Ioban®). * Hospital stay of \>14 days immediately prior to scheduled CABG surgery. * Use of chemotherapy agents, within 30 days prior to Visit 1 screening. * Scheduled for additional chemotherapy for the duration of the study. * Known positive Human Immunodeficiency Virus (HIV) with a CD4 count \< 350 mm3. If HIV status is not known, the subject is not excluded. * Currently taking antibiotics for an infection (within 30 days prior to Visit 1). * Has had therapeutic radiation to the chest within 30 days of visit 1. This does not in…